Global Sartan-series Drugs Market Research Report 2025(Status and Outlook)

March 2025 | 161 pages | ID: GA99EB387D3CEN
Bosson Research

Abstracts

Report Overview

Sartan-series drugs are one of the commonly used clinical antihypertensive drugs, ending with 'sartan', such as losartan, valsartan, telmisartan, also known as angiotensin II receptor antagonists or Angiotensin receptor blocker (ARBs). They include irbesartan, valsartan, losartan and candesartan. If the name of a medicine ends in ‘sartan’, it is an ARB.

This report provides a deep insight into the global Sartan-series Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Sartan-series Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Sartan-series Drugs market in any manner.

Global Sartan-series Drugs Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Merck & Co

Sanofi

Pfizer

Bayer

AstraZeneca

Daiichi Sankyo

Takeda

Bristol-Myers Squibb Company

Boehringer Ingelheim

Abbott

Teva Pharmaceutical

Shenzhen Salubris Pharmaceuticals

Market Segmentation (by Type)

Losartan

Valsartan

Irbesartan

Telmisartan

Olmesartan

Candesartan

Sacubitril/valsartan

Others

Market Segmentation (by Application)

Hospital Pharmaty

Retail Pharmacy

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Sartan-series Drugs Market
• Overview of the regional outlook of the Sartan-series Drugs Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Sartan-series Drugs Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Sartan-series Drugs
1.2 Key Market Segments
  1.2.1 Sartan-series Drugs Segment by Type
  1.2.2 Sartan-series Drugs Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 SARTAN-SERIES DRUGS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Sartan-series Drugs Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Sartan-series Drugs Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 SARTAN-SERIES DRUGS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Sartan-series Drugs Product Life Cycle
3.3 Global Sartan-series Drugs Sales by Manufacturers (2020-2025)
3.4 Global Sartan-series Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Sartan-series Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Sartan-series Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Sartan-series Drugs Manufacturing Sites, Area Served, Product Type
3.8 Sartan-series Drugs Market Competitive Situation and Trends
  3.8.1 Sartan-series Drugs Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Sartan-series Drugs Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 SARTAN-SERIES DRUGS INDUSTRY CHAIN ANALYSIS

4.1 Sartan-series Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF SARTAN-SERIES DRUGS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Sartan-series Drugs Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Sartan-series Drugs Market
5.7 ESG Ratings of Leading Companies

6 SARTAN-SERIES DRUGS MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Sartan-series Drugs Sales Market Share by Type (2020-2025)
6.3 Global Sartan-series Drugs Market Size Market Share by Type (2020-2025)
6.4 Global Sartan-series Drugs Price by Type (2020-2025)

7 SARTAN-SERIES DRUGS MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Sartan-series Drugs Market Sales by Application (2020-2025)
7.3 Global Sartan-series Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Sartan-series Drugs Sales Growth Rate by Application (2020-2025)

8 SARTAN-SERIES DRUGS MARKET SALES BY REGION

8.1 Global Sartan-series Drugs Sales by Region
  8.1.1 Global Sartan-series Drugs Sales by Region
  8.1.2 Global Sartan-series Drugs Sales Market Share by Region
8.2 Global Sartan-series Drugs Market Size by Region
  8.2.1 Global Sartan-series Drugs Market Size by Region
  8.2.2 Global Sartan-series Drugs Market Size Market Share by Region
8.3 North America
  8.3.1 North America Sartan-series Drugs Sales by Country
  8.3.2 North America Sartan-series Drugs Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Sartan-series Drugs Sales by Country
  8.4.2 Europe Sartan-series Drugs Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Sartan-series Drugs Sales by Region
  8.5.2 Asia Pacific Sartan-series Drugs Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Sartan-series Drugs Sales by Country
  8.6.2 South America Sartan-series Drugs Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Sartan-series Drugs Sales by Region
  8.7.2 Middle East and Africa Sartan-series Drugs Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 SARTAN-SERIES DRUGS MARKET PRODUCTION BY REGION

9.1 Global Production of Sartan-series Drugs by Region(2020-2025)
9.2 Global Sartan-series Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Sartan-series Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Sartan-series Drugs Production
  9.4.1 North America Sartan-series Drugs Production Growth Rate (2020-2025)
  9.4.2 North America Sartan-series Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Sartan-series Drugs Production
  9.5.1 Europe Sartan-series Drugs Production Growth Rate (2020-2025)
  9.5.2 Europe Sartan-series Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Sartan-series Drugs Production (2020-2025)
  9.6.1 Japan Sartan-series Drugs Production Growth Rate (2020-2025)
  9.6.2 Japan Sartan-series Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Sartan-series Drugs Production (2020-2025)
  9.7.1 China Sartan-series Drugs Production Growth Rate (2020-2025)
  9.7.2 China Sartan-series Drugs Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 Novartis
  10.1.1 Novartis Basic Information
  10.1.2 Novartis Sartan-series Drugs Product Overview
  10.1.3 Novartis Sartan-series Drugs Product Market Performance
  10.1.4 Novartis Business Overview
  10.1.5 Novartis SWOT Analysis
  10.1.6 Novartis Recent Developments
10.2 Merck and Co
  10.2.1 Merck and Co Basic Information
  10.2.2 Merck and Co Sartan-series Drugs Product Overview
  10.2.3 Merck and Co Sartan-series Drugs Product Market Performance
  10.2.4 Merck and Co Business Overview
  10.2.5 Merck and Co SWOT Analysis
  10.2.6 Merck and Co Recent Developments
10.3 Sanofi
  10.3.1 Sanofi Basic Information
  10.3.2 Sanofi Sartan-series Drugs Product Overview
  10.3.3 Sanofi Sartan-series Drugs Product Market Performance
  10.3.4 Sanofi Business Overview
  10.3.5 Sanofi SWOT Analysis
  10.3.6 Sanofi Recent Developments
10.4 Pfizer
  10.4.1 Pfizer Basic Information
  10.4.2 Pfizer Sartan-series Drugs Product Overview
  10.4.3 Pfizer Sartan-series Drugs Product Market Performance
  10.4.4 Pfizer Business Overview
  10.4.5 Pfizer Recent Developments
10.5 Bayer
  10.5.1 Bayer Basic Information
  10.5.2 Bayer Sartan-series Drugs Product Overview
  10.5.3 Bayer Sartan-series Drugs Product Market Performance
  10.5.4 Bayer Business Overview
  10.5.5 Bayer Recent Developments
10.6 AstraZeneca
  10.6.1 AstraZeneca Basic Information
  10.6.2 AstraZeneca Sartan-series Drugs Product Overview
  10.6.3 AstraZeneca Sartan-series Drugs Product Market Performance
  10.6.4 AstraZeneca Business Overview
  10.6.5 AstraZeneca Recent Developments
10.7 Daiichi Sankyo
  10.7.1 Daiichi Sankyo Basic Information
  10.7.2 Daiichi Sankyo Sartan-series Drugs Product Overview
  10.7.3 Daiichi Sankyo Sartan-series Drugs Product Market Performance
  10.7.4 Daiichi Sankyo Business Overview
  10.7.5 Daiichi Sankyo Recent Developments
10.8 Takeda
  10.8.1 Takeda Basic Information
  10.8.2 Takeda Sartan-series Drugs Product Overview
  10.8.3 Takeda Sartan-series Drugs Product Market Performance
  10.8.4 Takeda Business Overview
  10.8.5 Takeda Recent Developments
10.9 Bristol-Myers Squibb Company
  10.9.1 Bristol-Myers Squibb Company Basic Information
  10.9.2 Bristol-Myers Squibb Company Sartan-series Drugs Product Overview
  10.9.3 Bristol-Myers Squibb Company Sartan-series Drugs Product Market Performance
  10.9.4 Bristol-Myers Squibb Company Business Overview
  10.9.5 Bristol-Myers Squibb Company Recent Developments
10.10 Boehringer Ingelheim
  10.10.1 Boehringer Ingelheim Basic Information
  10.10.2 Boehringer Ingelheim Sartan-series Drugs Product Overview
  10.10.3 Boehringer Ingelheim Sartan-series Drugs Product Market Performance
  10.10.4 Boehringer Ingelheim Business Overview
  10.10.5 Boehringer Ingelheim Recent Developments
10.11 Abbott
  10.11.1 Abbott Basic Information
  10.11.2 Abbott Sartan-series Drugs Product Overview
  10.11.3 Abbott Sartan-series Drugs Product Market Performance
  10.11.4 Abbott Business Overview
  10.11.5 Abbott Recent Developments
10.12 Teva Pharmaceutical
  10.12.1 Teva Pharmaceutical Basic Information
  10.12.2 Teva Pharmaceutical Sartan-series Drugs Product Overview
  10.12.3 Teva Pharmaceutical Sartan-series Drugs Product Market Performance
  10.12.4 Teva Pharmaceutical Business Overview
  10.12.5 Teva Pharmaceutical Recent Developments
10.13 Shenzhen Salubris Pharmaceuticals
  10.13.1 Shenzhen Salubris Pharmaceuticals Basic Information
  10.13.2 Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Product Overview
  10.13.3 Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Product Market Performance
  10.13.4 Shenzhen Salubris Pharmaceuticals Business Overview
  10.13.5 Shenzhen Salubris Pharmaceuticals Recent Developments

11 SARTAN-SERIES DRUGS MARKET FORECAST BY REGION

11.1 Global Sartan-series Drugs Market Size Forecast
11.2 Global Sartan-series Drugs Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Sartan-series Drugs Market Size Forecast by Country
  11.2.3 Asia Pacific Sartan-series Drugs Market Size Forecast by Region
  11.2.4 South America Sartan-series Drugs Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Sartan-series Drugs by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Sartan-series Drugs Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Sartan-series Drugs by Type (2026-2033)
  12.1.2 Global Sartan-series Drugs Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Sartan-series Drugs by Type (2026-2033)
12.2 Global Sartan-series Drugs Market Forecast by Application (2026-2033)
  12.2.1 Global Sartan-series Drugs Sales (K MT) Forecast by Application
  12.2.2 Global Sartan-series Drugs Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Sartan-series Drugs Market Size Comparison by Region (M USD)
Table 5. Global Sartan-series Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Sartan-series Drugs Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Sartan-series Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Sartan-series Drugs Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sartan-series Drugs as of 2024)
Table 10. Global Market Sartan-series Drugs Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Sartan-series Drugs Manufacturing Sites and Area Served
Table 12. Manufacturers Sartan-series Drugs Product Type
Table 13. Global Sartan-series Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Sartan-series Drugs Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Sartan-series Drugs Sales by Type (K MT)
Table 25. Global Sartan-series Drugs Market Size by Type (M USD)
Table 26. Global Sartan-series Drugs Sales (K MT) by Type (2020-2025)
Table 27. Global Sartan-series Drugs Sales Market Share by Type (2020-2025)
Table 28. Global Sartan-series Drugs Market Size (M USD) by Type (2020-2025)
Table 29. Global Sartan-series Drugs Market Size Share by Type (2020-2025)
Table 30. Global Sartan-series Drugs Price (USD/MT) by Type (2020-2025)
Table 31. Global Sartan-series Drugs Sales (K MT) by Application
Table 32. Global Sartan-series Drugs Market Size by Application
Table 33. Global Sartan-series Drugs Sales by Application (2020-2025) & (K MT)
Table 34. Global Sartan-series Drugs Sales Market Share by Application (2020-2025)
Table 35. Global Sartan-series Drugs Market Size by Application (2020-2025) & (M USD)
Table 36. Global Sartan-series Drugs Market Share by Application (2020-2025)
Table 37. Global Sartan-series Drugs Sales Growth Rate by Application (2020-2025)
Table 38. Global Sartan-series Drugs Sales by Region (2020-2025) & (K MT)
Table 39. Global Sartan-series Drugs Sales Market Share by Region (2020-2025)
Table 40. Global Sartan-series Drugs Market Size by Region (2020-2025) & (M USD)
Table 41. Global Sartan-series Drugs Market Size Market Share by Region (2020-2025)
Table 42. North America Sartan-series Drugs Sales by Country (2020-2025) & (K MT)
Table 43. North America Sartan-series Drugs Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Sartan-series Drugs Sales by Country (2020-2025) & (K MT)
Table 45. Europe Sartan-series Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Sartan-series Drugs Sales by Region (2020-2025) & (K MT)
Table 47. Asia Pacific Sartan-series Drugs Market Size by Region (2020-2025) & (M USD)
Table 48. South America Sartan-series Drugs Sales by Country (2020-2025) & (K MT)
Table 49. South America Sartan-series Drugs Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Sartan-series Drugs Sales by Region (2020-2025) & (K MT)
Table 51. Middle East and Africa Sartan-series Drugs Market Size by Region (2020-2025) & (M USD)
Table 52. Global Sartan-series Drugs Production (K MT) by Region(2020-2025)
Table 53. Global Sartan-series Drugs Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Sartan-series Drugs Revenue Market Share by Region (2020-2025)
Table 55. Global Sartan-series Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 56. North America Sartan-series Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. Europe Sartan-series Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Japan Sartan-series Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. China Sartan-series Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. Novartis Basic Information
Table 61. Novartis Sartan-series Drugs Product Overview
Table 62. Novartis Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 63. Novartis Business Overview
Table 64. Novartis SWOT Analysis
Table 65. Novartis Recent Developments
Table 66. Merck and Co Basic Information
Table 67. Merck and Co Sartan-series Drugs Product Overview
Table 68. Merck and Co Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 69. Merck and Co Business Overview
Table 70. Merck and Co SWOT Analysis
Table 71. Merck and Co Recent Developments
Table 72. Sanofi Basic Information
Table 73. Sanofi Sartan-series Drugs Product Overview
Table 74. Sanofi Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Sanofi Business Overview
Table 76. Sanofi SWOT Analysis
Table 77. Sanofi Recent Developments
Table 78. Pfizer Basic Information
Table 79. Pfizer Sartan-series Drugs Product Overview
Table 80. Pfizer Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 81. Pfizer Business Overview
Table 82. Pfizer Recent Developments
Table 83. Bayer Basic Information
Table 84. Bayer Sartan-series Drugs Product Overview
Table 85. Bayer Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Bayer Business Overview
Table 87. Bayer Recent Developments
Table 88. AstraZeneca Basic Information
Table 89. AstraZeneca Sartan-series Drugs Product Overview
Table 90. AstraZeneca Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Recent Developments
Table 93. Daiichi Sankyo Basic Information
Table 94. Daiichi Sankyo Sartan-series Drugs Product Overview
Table 95. Daiichi Sankyo Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 96. Daiichi Sankyo Business Overview
Table 97. Daiichi Sankyo Recent Developments
Table 98. Takeda Basic Information
Table 99. Takeda Sartan-series Drugs Product Overview
Table 100. Takeda Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 101. Takeda Business Overview
Table 102. Takeda Recent Developments
Table 103. Bristol-Myers Squibb Company Basic Information
Table 104. Bristol-Myers Squibb Company Sartan-series Drugs Product Overview
Table 105. Bristol-Myers Squibb Company Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 106. Bristol-Myers Squibb Company Business Overview
Table 107. Bristol-Myers Squibb Company Recent Developments
Table 108. Boehringer Ingelheim Basic Information
Table 109. Boehringer Ingelheim Sartan-series Drugs Product Overview
Table 110. Boehringer Ingelheim Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 111. Boehringer Ingelheim Business Overview
Table 112. Boehringer Ingelheim Recent Developments
Table 113. Abbott Basic Information
Table 114. Abbott Sartan-series Drugs Product Overview
Table 115. Abbott Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Abbott Business Overview
Table 117. Abbott Recent Developments
Table 118. Teva Pharmaceutical Basic Information
Table 119. Teva Pharmaceutical Sartan-series Drugs Product Overview
Table 120. Teva Pharmaceutical Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 121. Teva Pharmaceutical Business Overview
Table 122. Teva Pharmaceutical Recent Developments
Table 123. Shenzhen Salubris Pharmaceuticals Basic Information
Table 124. Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Product Overview
Table 125. Shenzhen Salubris Pharmaceuticals Sartan-series Drugs Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 126. Shenzhen Salubris Pharmaceuticals Business Overview
Table 127. Shenzhen Salubris Pharmaceuticals Recent Developments
Table 128. Global Sartan-series Drugs Sales Forecast by Region (2026-2033) & (K MT)
Table 129. Global Sartan-series Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 130. North America Sartan-series Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 131. North America Sartan-series Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 132. Europe Sartan-series Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 133. Europe Sartan-series Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 134. Asia Pacific Sartan-series Drugs Sales Forecast by Region (2026-2033) & (K MT)
Table 135. Asia Pacific Sartan-series Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. South America Sartan-series Drugs Sales Forecast by Country (2026-2033) & (K MT)
Table 137. South America Sartan-series Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Middle East and Africa Sartan-series Drugs Sales Forecast by Country (2026-2033) & (Units)
Table 139. Middle East and Africa Sartan-series Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Global Sartan-series Drugs Sales Forecast by Type (2026-2033) & (K MT)
Table 141. Global Sartan-series Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 142. Global Sartan-series Drugs Price Forecast by Type (2026-2033) & (USD/MT)
Table 143. Global Sartan-series Drugs Sales (K MT) Forecast by Application (2026-2033)
Table 144. Global Sartan-series Drugs Market Size Forecast by Application (2026-2033) & (M USD)
List of Figures
Figure 1. Product Picture of Sartan-series Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Sartan-series Drugs Market Size (M USD), 2024-2033
Figure 5. Global Sartan-series Drugs Market Size (M USD) (2020-2033)
Figure 6. Global Sartan-series Drugs Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Sartan-series Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Sartan-series Drugs Product Life Cycle
Figure 13. Sartan-series Drugs Sales Share by Manufacturers in 2024
Figure 14. Global Sartan-series Drugs Revenue Share by Manufacturers in 2024
Figure 15. Sartan-series Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Sartan-series Drugs Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Sartan-series Drugs Revenue in 2024
Figure 18. Industry Chain Map of Sartan-series Drugs
Figure 19. Global Sartan-series Drugs Market PEST Analysis
Figure 20. Global Sartan-series Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Sartan-series Drugs Market Share by Type
Figure 27. Sales Market Share of Sartan-series Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Sartan-series Drugs by Type in 2024
Figure 29. Market Size Share of Sartan-series Drugs by Type (2020-2025)
Figure 30. Market Size Share of Sartan-series Drugs by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Sartan-series Drugs Market Share by Application
Figure 33. Global Sartan-series Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Sartan-series Drugs Sales Market Share by Application in 2024
Figure 35. Global Sartan-series Drugs Market Share by Application (2020-2025)
Figure 36. Global Sartan-series Drugs Market Share by Application in 2024
Figure 37. Global Sartan-series Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Sartan-series Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Sartan-series Drugs Market Size Market Share by Region (2020-2025)
Figure 40. North America Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Sartan-series Drugs Sales Market Share by Country in 2024
Figure 43. North America Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Sartan-series Drugs Market Size Market Share by Country in 2024
Figure 45. U.S. Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Sartan-series Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Sartan-series Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Sartan-series Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Sartan-series Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Sartan-series Drugs Sales Market Share by Country in 2024
Figure 53. Europe Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Sartan-series Drugs Market Size Market Share by Country in 2024
Figure 55. Germany Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Sartan-series Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Sartan-series Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Sartan-series Drugs Market Size Market Share by Region in 2024
Figure 68. China Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Sartan-series Drugs Sales and Growth Rate (K MT)
Figure 79. South America Sartan-series Drugs Sales Market Share by Country in 2024
Figure 80. South America Sartan-series Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Sartan-series Drugs Market Size Market Share by Country in 2024
Figure 82. Brazil Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Sartan-series Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Sartan-series Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Sartan-series Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Sartan-series Drugs Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Sartan-series Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Sartan-series Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Sartan-series Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Sartan-series Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Sartan-series Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Sartan-series Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Sartan-series Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Sartan-series Drugs Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Sartan-series Drugs Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Sartan-series Drugs Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Sartan-series Drugs Market Share Forecast by Type (2026-2033)
Figure 111. Global Sartan-series Drugs Sales Forecast by Application (2026-2033)
Figure 112. Global Sartan-series Drugs Market Share Forecast by Application (2026-2033)